Rare diseases
Investigational molecules
Locations
Back to France478 clinical trials in Bron, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Nipocalimab in Pregnant Women at Risk of Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
FranceStudy on Azathioprine for Preventing Relapse in Patients with Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOG-AD) After First Attack
FranceStudy on the Effectiveness and Safety of Rituximab for Patients with Progressive Interstitial Lung Disease with Inflammation
FranceStudy on Aspirin for Preventing Preeclampsia in First-Time Pregnant Women Using Assisted Reproductive Technology
FranceStudy on Long-term Effects and Safety of Odevixibat in Children with Biliary Atresia
FranceStudy on Mitotane Alone or with Cisplatin and Etoposide for Patients with High-Risk Adrenocortical Carcinoma After Surgery
FranceStudy on Switching from Tacrolimus or Ciclosporin to Belatacept for Adolescents with Kidney Transplants
FranceStudy on Fluorodopa (18F) for Diagnosing Low-Grade Glioma in Patients Without MRI Contrast Enhancement
FranceStudy on the Effects of Azetukalner in Patients with Focal-Onset Seizures
FranceStudy on the Effects of XEN1101 and Placebo for Patients with Primary Generalized Tonic-Clonic Seizures
FranceStudy on Long-Term Safety and Effectiveness of Vanzacaftor, Tezacaftor, and Deutivacaftor for Cystic Fibrosis in Patients Aged 1 Year and Older
FranceStudy of Microdystrophin (GNT0004) Gene Therapy for Duchenne Muscular Dystrophy in Boys Who Can Walk
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple sclerosis and Parkinson's disease, including advanced PET imaging studies and evaluation of novel therapeutic approaches.
Studies include neuroinflammation assessment and serotonergic receptor expression analysis.
Comprehensive research into glioblastoma treatment approaches, combining innovative therapies with standard protocols.
Integration of radiotherapy, chemotherapy, and novel therapeutic agents for improved patient outcomes.
Targeted research on rare conditions including Dravet Syndrome and Alagille syndrome, focusing on innovative therapeutic approaches.
Emphasis on developing effective treatments for previously undertreated rare conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
